Whole genome analysis and homology modeling of SARS-CoV-2 Indian isolate reveals potent FDA approved drug choice for treating COVID-19

References

• Adedeji, A. O., Singh, K., Kassim, A., Coleman, C. M., Elliott, R., Weiss, S. R., Frieman, M. B., & Sarafianos, S. G. (2014). Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrobial Agents and Chemotherapy, 58(8), 4894–4898. https://doi.org/10.1128/AAC.02994-14
   PubMed Web of Science ®Google Scholar
• Ananthula,  H. K., Parker, S., Touchette, E., Buller, R. M., Patel, G., Kalman, D., Salzer, J. S., Gallardo-Romero, N., Olson, V., Damon, I. K., Moir-Savitz, T., Sallans, L., Werner, M. H., Sherwin, C. M., & Desai, P. B. (2018). Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents. BMC Pharmacology and Toxicology, 19(80),1-11. https://doi.org/10.1186/s40360-018-0270-x
   Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235-242. https://doi.org/10.1093/nar/28.1.235
   Google Scholar
• Biovia, D. S. (2017). Discovery studio modeling environment.
   Google Scholar
• Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., & Shaw, D. E. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. In SC’06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing (pp. 43–43). IEEE.
   Google Scholar
• Cheng, V. C. C.,Wong, S.-C.,Chen, J. H. K.,Yip, C. C. Y.,Chuang, V. W. M.,Tsang, O. T. Y.,Sridhar, S.,Chan, J. F. W.,Ho, P.-L., &Yuen, K.-Y. (2020). Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infection Control & Hospital Epidemiology, 41(5), 493–498. https://doi.org/10.1017/ice.2020.58
   PubMed Web of Science ®Google Scholar
• Cheng, F., Istvan, I., Kovacskovacs, A., Laszlo, A.-L., & Lászlóbarabási, L. (2019). Network-based prediction of drug combinations. Nature Communications, 10(1197), 1-11. https://doi.org/10.1038/s41467-019-09186-x
   Web of Science ®Google Scholar
• Choudhary, M. I.,Shaikh, M.,Tul-Wahab, Atia., &Ur-Rahman, Atta. (2020). In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. PloS One, 15(7), e0235030. https://doi.org/10.1371/journal.pone.0235030 32706783
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). (No title). In Prorein science (Vol. 2). Cambridge University Press.
   Google Scholar
• de Lima, W. A., Pereira, A. F., de Castro, A. A., da Cunha, E. F. F., & Ramalho, T. C. (2016). Flexibility in the molecular design of acetylcholinesterase reactivators: Probing representative conformations by chemometric techniques and docking/QM calculations. Letters in Drug Design & Discovery, 13 (5), 360–371. https://doi.org/10.2174/1570180812666150918191550
   Web of Science ®Google Scholar
• Eisenberg, D., Lüthy, R., & Bowie, J. U. (1997). VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods in Enzymology, 277, 396–404. https://doi.org/10.1016/S0076-6879(97)77022-8
   PubMed Web of Science ®Google Scholar
• Fairman-Williams, M. E., Guenther, U. P., & Jankowsky, E. (2010). SF1 and SF2 helicases: family matters. Current Opinion in Structural Biology, 20(3), 313–324. https://doi.org/10.1016/j.sbi.2010.03.011
   PubMed Web of Science ®Google Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Ghosh, A., Chakraborty, M., Chandra, A., & Alam, M. P. (2021). Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M pro) of SARS-CoV-2. Journal of Molecular Modeling, 27(3), 97. https://doi.org/10.1007/s00894-021-04703-6/Published
   PubMed Web of Science ®Google Scholar
• Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., Penzar, D., Perlman, S., Poon, L. L., Samborskiy, D., Sidorov, I. A., Sola, I., & Ziebuhr, J. (2020). Severe acute respiratory syndrome-related coronavirus: The species and its viruses—A statement of the Coronavirus Study Group. bioRxiv preprint. https://doi.org/10.1101/2020.02.07.937862
   Google Scholar
• Graham, R. L., Sparks, J. S., Eckerle, L. D., Sims, A. C., & Denison, M. R. (2008). SARS coronavirus replicase proteins in pathogenesis. Virus Research, 133(1), 88–100. https://doi.org/10.1016/j.virusres.2007.02.017
   PubMed Web of Science ®Google Scholar
• Gurung, A. B. (2020). In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors. Gene Reports, 21, 100860. https://doi.org/10.1016/j.genrep.2020.100860
   PubMed Web of Science ®Google Scholar
• Hetenyi, C., & Van der Spoel, D. (2002). Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Science, 11(7), 1729–1737. https://doi.org/10.1110/ps.0202302
   PubMed Web of Science ®Google Scholar
• Hillen, H. S., Kokic, G., Farnung, L., Dienemann, C., Tegunov, D., & Cramer, P. (2020). Structure of replicating SARS-CoV-2 polymerase. Nature, 584(7819), 154–156. https://doi.org/10.1038/s41586-020-2368-8
   PubMed Web of Science ®Google Scholar
• Hosseini, F. S., & Amanlou, M. (2020). Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study. Life Sciences, 258, 118205. https://doi.org/10.1016/j.lfs.2020.118205
   PubMed Web of Science ®Google Scholar
• Huang, Y., Yang, C., Xu, X.-F., Xu, W., & Liu, S.-W. (2020). Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica, 41, 1141–1149. https://doi.org/10.1038/s41401-020-0485-4
   PubMed Web of Science ®Google Scholar
• Irwin, J. K., & Shoichet, B. (2016). Docking screens for novel ligands conferring new biology. Journal of Medicinal Chemistry, 59(9), 4103–4120. https://doi.org/10.1021/acs.jmedchem.5b02008
   PubMed Web of Science ®Google Scholar
• Jia, Z.,Yan, L.,Ren, Z.,Wu, L.,Wang, J.,Guo, J.,Zheng, L.,Ming, Z.,Zhang, L.,Lou, Z., &Rao, Z. (2019). Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis. Nucleic Acids Research, 47(12), 6538–6550. https://doi.org/10.1093/nar/gkz409 31131400
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Kalbhor, M. S.,Bhowmick, S.,Alanazi, A. M.,Patil, P. C., &Islam, M. A. (2021). Multi-step molecular docking and dynamics simulation-based screening of large antiviral specific chemical libraries for identification of Nipah virus glycoprotein inhibitors. Biophysical Chemistry, 270, 106537.https://doi.org/10.1016/j.bpc.2020.106537.
   PubMed Web of Science ®Google Scholar
• Kumar, B. K., Faheem, Sekhar, K., Ojha, R., Prajapati, V. K., Pai, A., & Murugesan, S. (2020). Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. Journal of Biomolecular Structure and Dynamics, 2020, 1–24. https://doi.org/10.1080/07391102.2020.1824814
   Google Scholar
• Kumar, S., Sharma, P. P., Shankar, U., Kumar, D., Joshi, S. K., Pena, L., Durvasula, R., Kumar, A., Kempaiah, P., & Rathi, B. (2020). Discovery of new hydroxyethylamine analogs against 3CL pro protein target of SARS-CoV-2: Molecular docking, molecular dynamics simulation, and structure − activity relationship studies. Journal of Chemical Information and Modeling, 60, 5754–5770. https://doi.org/10.1021/acs.jcim.0c00326
   PubMed Web of Science ®Google Scholar
• Kumar, S., Stecher, G., Li, M., Knyaz, C., & Tamura, K. (2008). MEGA X: Molecular evolutionary genetics analysis across computing platforms. Molecular Biology and Evolution, 35, 1547–1549. https://doi.org/10.1093/molbev/msy096
   Google Scholar
• Lepelletier, D., Grandbastien, B., Michael., & Smart, R B N. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID. Annals of Oncology, 2020, 19–21.
   Google Scholar
• Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins: Structure, Function and Bioinformatics, 79(10), 2794–2812. https://doi.org/10.1002/prot.23106
   PubMed Web of Science ®Google Scholar
• Lokhande, K. B., Doiphode, S., Vyas, R., & Swamy, K. V. (2021). Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19. Journal of Biomolecular Structure & Dynamics, 39(18), 7294–7305. https://doi.org/10.1080/07391102.2020.1805019
   PubMed Web of Science ®Google Scholar
• Meanwell, N. A. (2011). Improving drug candidates by design: A focus on physicochemical properties as a means of improving compound disposition and safety. Chemical Research in Toxicology, 24(9), 1420–1456. https://doi.org/10.1021/tx200211v
   PubMed Web of Science ®Google Scholar
• Merrill, J. T., Erkan, D., Winakur, J., & James, J. A. (2020). Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nature Reviews Rheumatology, 16, 581–589. https://doi.org/10.1038/s41584-020-0474-5
   PubMed Web of Science ®Google Scholar
• Molavi, Z., Razi, S., Mirmotalebisohi, S. A., Adibi, A., Sameni, M., Karami, F., Niazi, V., Niknam, Z., Aliashrafi, M., Taheri, M., Ghafouri-Fard, S., Jeibouei, S., Mahdian, S., Zali, H., Ranjbar, M. M., & Yazdani, M. (2021). Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 138, 111544. https://doi.org/10.1016/j.biopha.2021.111544
   PubMed Web of Science ®Google Scholar
• Noor, H., Ikram, A., Rathinavel, T., Kumarasamy, S., Nasir Iqbal, M., & Bashir, Z. (2021). Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19–A computational modeling. Journal of Biomolecular Structure and Dynamics, 2021, 1–16. https://doi.org/10.1080/07391102.2021.1873190
   Google Scholar
• Oellien, F., & Nicklaus, M. C. (2004). Online SMILES translator and structure file generator.
   Google Scholar
• Oude Munnink, B. B., Nieuwenhuijse, D. F., Stein, M., O'Toole, Á., Haverkate, M., Mollers, M., Kamga, S. K., Schapendonk, C., Pronk, M., Lexmond, P., van der Linden, A., Bestebroer, T., Chestakova, I., Overmars, R. J., van Nieuwkoop, S., Molenkamp, R., van der Eijk, A. A., GeurtsvanKessel, C., Vennema, H., … Koopmans, M. (2020). Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands. Nature Medicine, 26(9), 1405–1410. https://doi.org/10.1038/s41591-020-0997-y
   PubMed Web of Science ®Google Scholar
• Perlman, S., & Netland, J. (2009). Coronaviruses post-SARS: Update on replication and pathogenesis. Nature Reviews. Microbiology, 7(6), 439–450. https://doi.org/10.1038/nrmicro2147
   PubMed Web of Science ®Google Scholar
• Prajapati, L., Khandelwal, R., Yogalakshmi, K. N., Munshi, A., & Nayarisseri, A. (2020). Computer-aided structure prediction of bluetongue virus coat protein VP2 assisted by optimized potential for liquid simulations (OPLS). Current Topics in Medicinal Chemistry, 20(19), 1720–1732. https://doi.org/10.2174/1568026620666200516153753
   PubMedGoogle Scholar
• Santiago, E., & Caballero, A. (2020). The value of targeting recombination as a strategy against coronavirus diseases. Heredity, 125(4), 169–172. https://doi.org/10.1038/s41437-020-0337-5
   PubMed Web of Science ®Google Scholar
• Schwede, T., Rgen Kopp, J., Guex, N., & Peitsch, M. C. (2003). SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Research, 31(13), 3381–3385. https://doi.org/10.1093/nar/gkg520
   PubMed Web of Science ®Google Scholar
• Scott, W. R., Hünenberger, P. H., Tironi, I. G., Mark, A. E., Billeter, S. R., Fennen, J., Torda, A. E., Huber, T., Krüger, P., & van Gunsteren, W. F. (1999). The GROMOS biomolecular simulation program package. The Journal of Physical Chemistry A, 103(19), 3596–3607. https://doi.org/10.1021/jp984217f
   Web of Science ®Google Scholar
• Shanker, A. K., Bhanu, D., Alluri, A., & Gupta, S. (2020). Whole-genome sequence analysis and homology modelling of the main protease and non-structural protein 3 of SARS-CoV-2 reveal an aza-peptide and a lead inhibitor with possible antiviral properties. New Journal of Chemistry, 44(22), 9202–9212. https://doi.org/10.1039/D0NJ00974A
   Web of Science ®Google Scholar
• Thirumalaisamy, R., Aroulmoji, V., Iqbal, M. N., Deepa, M., Sivasankar, C., Khan, R., & Selvankumar, T. (2021). Molecular insights of hyaluronic acid-hydroxychloroquine conjugate as a promising drug in targeting SARS-CoV-2 viral proteins. Journal of Molecular Structure, 1238, 130457. https://doi.org/10.1016/j.molstruc.2021.130457
   PubMed Web of Science ®Google Scholar
• Toyoshima, Y., Nemoto, K., Matsumoto, S., Nakamura, Y., & Kiyotani, K. (2020). SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. Journal of Human Genetics, 65(12), 1075–1082. https://doi.org/10.1038/s10038-020-0808-9
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), NA–NA. https://doi.org/10.1002/jcc.21334
   Web of Science ®Google Scholar
• Wakchaure, P., Ghosh, S., & Ganguly, B. (2020). Revealing the inhibition mechanism of RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 by remdesivir and nucleotide analogues: A molecular dynamics simulation study. The Journal of Physical Chemistry. B, 124(47), 10641–10652. https://doi.org/10.1021/acs.jpcb.0c06747
   PubMed Web of Science ®Google Scholar
• Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Chetvernin, V., Church, D. M., DiCuccio, M., Edgar, R., Federhen, S., Feolo, M., Geer, L. Y., Helmberg, W., Kapustin, Y., Khovayko, O., Landsman, D., Lipman, D. J., Madden, T. L., Maglott, D. R., … Yaschenko, E. (2007). Database resources of the National Center for Biotechnology Information. Nucleic Acids Research, 36(Database), D13–D21. https://doi.org/10.1093/nar/gkm1000
   PubMedGoogle Scholar
• Yadav, P. D., Potdar, V. A., Choudhary, M. L., Nyayanit, D. A., Agrawal, M., Jadhav, S. M., Majumdar, T. D., Shete-Aich, A., Basu, A., Abraham, P., & Cherian, S. S. (2020). Full-genome sequences of the first two SARS-CoV-2 viruses from India. The Indian Journal of Medical Research, 151(2–3), 200–209.
   PubMed Web of Science ®Google Scholar
• Yoshino, R., Yasuo, N., & Sekijima, M. (2020). Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates. Scientific Reports, 10, 12493. https://doi.org/10.1038/s41598-020-69337-9
   PubMed Web of Science ®Google Scholar
• Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020). Cell Discovery Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6, 14. https://doi.org/10.1038/s41421-020-0153-3
   PubMed Web of Science ®Google Scholar
• Zirui Tay, M., Meng Poh, C., Rénia, L., MacAry, P. A., P., & Ng, L. F. (2019). The trinity of COVID-19: Immunity, inflammation and intervention. Nature Reviews. Immunology, 20(6), 363–374. https://doi.org/10.1038/s41577-020-0311-8
   Web of Science ®Google Scholar